Michael Brundage
Biographic Data
| ID | 3577183 |
|---|---|
| NAME | Michael Brundage |
| GIVEN NAMES | Michael |
| FAMILY NAME | Brundage |
| SIGNATURE | BRUNDAGE M |
| AFFILIATIONS | Queen's University |
| ORCID | 0000-0002-5104-0497 |
| VERIFIED | Yes |
| TOTAL WORKS | 21 |
| TOTAL CITATIONS | 4 |
| AUTHOR COUNT | 21 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 1 |
Factors predicting missing instruments in three cancer randomized clinical trials
A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes: Introduction to the Supplement
Patients are increasingly being asked to complete standardized, validated questionnaires with regard to their symptoms, functioning, and well-being [ie, patient-reported outcomes (PROs)] as part of routine care. These PROs can be used to inform patients’ care and management, which we refer to as “PRO-cision Medicine.” For PRO-cision Medicine to be most effective, clinicians and patients need to be able to understand what the PRO scores mean and h…
In proportion: Approaches for displaying patient-reported outcome research study results as percentages responding to treatment
A pilot evaluation of the expanded prostate cancer index composite for clinical practice (Epic-CP) tool in Ontario
Making a picture worth a thousand numbers: Recommendations for graphically displaying patient-reported outcomes data
Preliminary evidence on the uptake, use and benefits of the Consort-PRO extension
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases
Presenting comparative study PRO results to clinicians and researchers: Beyond the eye of the beholder
Graphic formats for presenting PRO data differ in how accurately they are interpreted and how clear they are perceived to be. These findings will inform the development of best practices for optimally reporting PRO findings
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy
Communicating patient-reported outcome scores using graphic formats: Results from a mixed-methods evaluation
Integrating health-related quality of life findings from randomized clinical trials into practice: An international study of oncologists’ perspectives
Isoqol recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
Clinical Use of Health-Related Quality of Life Outcomes From Cancer Clinical Trials: Preliminary Results From a Survey of Oncologists
Introduction There have been increasing efforts aimed at enhancing patient-centered care and incorporating patients' voice into clinical practice. As such, a growing body of literature has recognized the importance of Health-Related Quality of Life (HRQOL) outcomes from clinical trials. HRQOL outcomes are often collected in Phase III randomized controlled trials (RCTs), along with survival data, morbidity, and toxicity data. HRQOL outcomes are me…
A knowledge translation challenge: Clinical use of quality of life data from cancer clinical trials
A conceptual framework for patient–provider communication: A tool in the PRO research tool box
Patient‐focussed decision‐making in early‐stage prostate cancer: Insights from a cognitively based decision aid
Purpose To study the cognitive processes of early‐stage prostate cancer patients as they determined which treatment they preferred, using our cognitively based decision aid. Method The aid was a one‐to‐one interview that included the structured presentation of information, listing exercises in which the patient identified attributes important to his decision, and trade‐off exercises to help him weigh and integrate those attributes together. At va…
Cancer patients' preferences for communicating clinical trial quality of life information: A qualitative study
Sleep disturbance in cancer patients
A decision aid for men with early stage prostate cancer: Theoretical basis and a test by surrogate patients
Background We developed a decision aid for patients with curable prostate cancer based on Svenson’s DiffCon Theory of Decision Making. This study was designed to determine if surrogate patients using the aid could understand the information presented, complete all tasks, show evidence of differentiation, and arrive at a preferred treatment choice. Methods Men, at least 50 years old and never diagnosed with prostate cancer, were recruited through …
Practical issues in assisting shared decision‐making
To facilitate treatment decision‐making, one aims to provide information, present it in a way that makes it as easy as possible to understand, and to help the decision‐maker through the cognitive processes that result in a treatment decision. Decision aids aim to accomplish just these goals and this paper identifies practical issues that we have encountered in creating a decision aid for men with early stage prostate cancer. We highlight the resu…
A treatment trade‐off based decision aid for patients with locally advanced non‐small cell lung cancer
Purpose To describe the structure and use of a decision aid for patients with locally advanced non‐small cell lung cancer (LA‐NSCLC) who are eligible for combined‐modality treatment (CMT) or for radiotherapy alone (RT). Methods The aid included a structured description of the treatment options and trade‐off exercises designed to help clarify the patient’s values for the relevant outcomes by determining the patient’s survival advantage threshold (…
Practical issues in assisting shared decision‐making
To facilitate treatment decision‐making, one aims to provide information, present it in a way that makes it as easy as possible to understand, and to help the decision‐maker through the cognitive processes that result in a treatment decision. Decision aids aim to accomplish just these goals and this paper identifies practical issues that we have encountered in creating a decision aid for men with early stage prostate cancer. We highlight the resu…
A treatment trade‐off based decision aid for patients with locally advanced non‐small cell lung cancer
Purpose To describe the structure and use of a decision aid for patients with locally advanced non‐small cell lung cancer (LA‐NSCLC) who are eligible for combined‐modality treatment (CMT) or for radiotherapy alone (RT). Methods The aid included a structured description of the treatment options and trade‐off exercises designed to help clarify the patient’s values for the relevant outcomes by determining the patient’s survival advantage threshold (…
A decision aid for men with early stage prostate cancer: Theoretical basis and a test by surrogate patients
Background We developed a decision aid for patients with curable prostate cancer based on Svenson’s DiffCon Theory of Decision Making. This study was designed to determine if surrogate patients using the aid could understand the information presented, complete all tasks, show evidence of differentiation, and arrive at a preferred treatment choice. Methods Men, at least 50 years old and never diagnosed with prostate cancer, were recruited through …
Sleep disturbance in cancer patients
Cancer patients' preferences for communicating clinical trial quality of life information: A qualitative study
Patient‐focussed decision‐making in early‐stage prostate cancer: Insights from a cognitively based decision aid
Purpose To study the cognitive processes of early‐stage prostate cancer patients as they determined which treatment they preferred, using our cognitively based decision aid. Method The aid was a one‐to‐one interview that included the structured presentation of information, listing exercises in which the patient identified attributes important to his decision, and trade‐off exercises to help him weigh and integrate those attributes together. At va…
A conceptual framework for patient–provider communication: A tool in the PRO research tool box
A knowledge translation challenge: Clinical use of quality of life data from cancer clinical trials
Isoqol recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
Clinical Use of Health-Related Quality of Life Outcomes From Cancer Clinical Trials: Preliminary Results From a Survey of Oncologists
Introduction There have been increasing efforts aimed at enhancing patient-centered care and incorporating patients' voice into clinical practice. As such, a growing body of literature has recognized the importance of Health-Related Quality of Life (HRQOL) outcomes from clinical trials. HRQOL outcomes are often collected in Phase III randomized controlled trials (RCTs), along with survival data, morbidity, and toxicity data. HRQOL outcomes are me…
Integrating health-related quality of life findings from randomized clinical trials into practice: An international study of oncologists’ perspectives
Communicating patient-reported outcome scores using graphic formats: Results from a mixed-methods evaluation
Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy
Preliminary evidence on the uptake, use and benefits of the Consort-PRO extension
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases
Presenting comparative study PRO results to clinicians and researchers: Beyond the eye of the beholder
Graphic formats for presenting PRO data differ in how accurately they are interpreted and how clear they are perceived to be. These findings will inform the development of best practices for optimally reporting PRO findings
In proportion: Approaches for displaying patient-reported outcome research study results as percentages responding to treatment
A pilot evaluation of the expanded prostate cancer index composite for clinical practice (Epic-CP) tool in Ontario
Making a picture worth a thousand numbers: Recommendations for graphically displaying patient-reported outcomes data
A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes: Introduction to the Supplement
Patients are increasingly being asked to complete standardized, validated questionnaires with regard to their symptoms, functioning, and well-being [ie, patient-reported outcomes (PROs)] as part of routine care. These PROs can be used to inform patients’ care and management, which we refer to as “PRO-cision Medicine.” For PRO-cision Medicine to be most effective, clinicians and patients need to be able to understand what the PRO scores mean and h…
Factors predicting missing instruments in three cancer randomized clinical trials
Medicine (20 works) · Internal Medicine (12 works) · Patient-Provider Communication in Healthcare (11 works) · Psychology (11 works) · Cancer survivorship and care (10 works) · Family medicine (9 works) · Nursing (9 works) · Cancer (8 works) · Clinical trial (8 works) · Computer Science (8 works)